Contract drug developer Almac has reached a milestone in its efforts to develop in-house therapeutics, taking its top prospect into Phase I trials. The company, which makes its money handling R&D ...

In its continuing expansion blitz, Almac has completed new two facilities at its headquarters in Craigavon, Northern Ireland, which will expand the capacity of the CDMO to package commercial ...

Almac Group, a CDMO based in Northern Ireland, is bumping up its expansion plans with a global hiring binge to fill 1,800 new positions in the next three years. The company said jobs in 120 ...

Pharmaceutical development and manufacturing giant Almac Group has posted record-breaking sales in the year to September 30, new figures show. It comes on the back of a period of phenomenal growth ...

Almac (www.almacgroup.com) offers a wide range of integrated development services that include translational genomics and diagnostic developments, GMP manufacture, and clinical trial services.

Almac’s Diagnostics business unit has announced that it will be the central service lab to perform the analytic phase and deliver to the clinicians the result of Exonhit AclarusDx™ diagnostic test.

Almac Discovery and Immune Therapy Holdings (ITH), a spin out company from the Karolinska Institute, Stockholm, today announced that they have engaged in a collaboration to develop a novel medical ...

The 14th Asian Logistics, Maritime and Aviation Conference (ALMAC) will take place on 18 and 19 November at the Hong Kong Convention and Exhibition Centre - Under the theme of "Shaping the Future ...